ES8609351A1 - Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico. - Google Patents

Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico.

Info

Publication number
ES8609351A1
ES8609351A1 ES547625A ES547625A ES8609351A1 ES 8609351 A1 ES8609351 A1 ES 8609351A1 ES 547625 A ES547625 A ES 547625A ES 547625 A ES547625 A ES 547625A ES 8609351 A1 ES8609351 A1 ES 8609351A1
Authority
ES
Spain
Prior art keywords
hydrosoluble
pharmaceutical compositions
antibiotic pharmaceutical
antibiotic
salified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547625A
Other languages
English (en)
Spanish (es)
Other versions
ES547625A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering SpA
Original Assignee
Schering SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering SpA filed Critical Schering SpA
Publication of ES547625A0 publication Critical patent/ES547625A0/es
Publication of ES8609351A1 publication Critical patent/ES8609351A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505Phosphonic acids containing oxirane groups; esters thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES547625A 1984-10-05 1985-10-04 Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico. Expired ES8609351A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4792/84A CH660306A5 (de) 1984-10-05 1984-10-05 Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.

Publications (2)

Publication Number Publication Date
ES547625A0 ES547625A0 (es) 1986-09-01
ES8609351A1 true ES8609351A1 (es) 1986-09-01

Family

ID=4282621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547625A Expired ES8609351A1 (es) 1984-10-05 1985-10-04 Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico.

Country Status (11)

Country Link
JP (1) JPS62223121A (de)
KR (1) KR860003012A (de)
AT (1) AT383736B (de)
BE (1) BE903369A (de)
CH (1) CH660306A5 (de)
DE (1) DE3535356A1 (de)
ES (1) ES8609351A1 (de)
FR (1) FR2571255B1 (de)
GB (1) GB2165152B (de)
IT (1) IT1201479B (de)
NL (1) NL8502712A (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH310498A (de) * 1951-11-14 1955-10-31 Waldhof Zellstoff Fab Verfahren zur Stabilisierung von Alkalisalzen von Adenosinpolyphosphorsäuren.
DE1767212B1 (de) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Verfahren zur Herstellung injizierbarer Arzneimittel
US3639590A (en) * 1967-07-25 1972-02-01 Merck & Co Inc Antibacterial composition containing (-) (cis-1 2-epoxypropyl) phosphoric acid
BE756953A (fr) * 1969-10-02 1971-04-01 Merck & Co Inc Potentialisation d'antibiotiques
IT1161974B (it) * 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
DE2813814A1 (de) * 1978-03-31 1979-10-18 Boehringer Mannheim Gmbh Hochwirksame, enteral resorbierbare pharmazeutische praeparate
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1097578B (it) * 1978-07-31 1985-08-31 Italchemi Spa Metodo per la preparazione di sali dell'acido (-)
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions

Also Published As

Publication number Publication date
GB2165152A (en) 1986-04-09
ES547625A0 (es) 1986-09-01
AT383736B (de) 1987-08-10
GB8524550D0 (en) 1985-11-06
DE3535356A1 (de) 1986-04-24
NL8502712A (nl) 1986-05-01
KR860003012A (ko) 1986-05-19
ATA287185A (de) 1987-01-15
FR2571255A1 (fr) 1986-04-11
JPS62223121A (ja) 1987-10-01
BE903369A (nl) 1986-02-03
IT1201479B (it) 1989-02-02
IT8522367A0 (it) 1985-10-04
GB2165152B (en) 1988-03-16
FR2571255B1 (fr) 1988-09-16
CH660306A5 (de) 1987-04-15

Similar Documents

Publication Publication Date Title
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
GR3018228T3 (en) Homogeneous mammalian hematopoietic stem cell composition.
IE45390L (en) Anti-caries composition
PT82127A (en) Process for the preparation of phenyl carbamates
DE3271532D1 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
CA2015186A1 (en) Nutrient composition
SE8901041L (sv) Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
GB2181647B (en) Compositions based on lysine and arginine salts.
DE3582895D1 (de) Peptid, dessen herstellung und benutzung.
AU4629885A (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
ES8609351A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico.
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
IL84551A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
ES8608861A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.
GB1051686A (de)
AU544742B2 (en) Prepare amides especially peptides
DE2965364D1 (en) Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same
JPS6463342A (en) Stabilization of glutathione-containing composition
ES2000182A6 (es) Procedimiento para la obtencion de (iso) ureas substituidas potenciadoras del rendimiento.
JPS5332193A (en) Preparation of l-glutamic acid by fermentation
ES8606259A1 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
ES8308832A1 (es) Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina.
ES8606248A1 (es) Un procedimiento para la produccion de una dihidroxifenil- glicina opticamente activa
ES2051788T3 (es) Un producto farmaceutico.
AU6387886A (en) Mitogenic peptides